SARS-CoV-2 immunogenicity: Is S protein the best target for vaccination?

Vaccine. 2022 May 20;40(23):3093-3095. doi: 10.1016/j.vaccine.2022.04.061. Epub 2022 Apr 22.

Authors

Tania Antonopoulou¹, Irene Athanassakis²

Affiliations

¹ Laboratory of Immunology, Department of Biology, University of Crete, Heraklion 70013, Crete, Greece.
² Laboratory of Immunology, Department of Biology, University of Crete, Heraklion 70013, Crete, Greece; Immune Recognition PCC, Heraklion 71500, Crete, Greece. Electronic address: athanire@uoc.gr.

No abstract available

MeSH terms

Antibodies, Viral
COVID-19* / prevention & control
Humans
Immunogenicity, Vaccine
SARS-CoV-2*
Spike Glycoprotein, Coronavirus
Vaccination

Substances

Antibodies, Viral
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2